Advancing Patient Access Through Novel Genetic Medicine

In partnership with Scribe Therapeutics, the Monash Victorian Heart Institute is pleased to invite you to an exclusive dinner meeting bringing together general practitioners and specialist clinicians to discuss a cardioprotective genetic medicine being investigated in clinical trials across Australia and New Zealand, and its potential impact on patient care.

As the healthcare professionals who often play a pivotal role in the early identification and ongoing management of patients with complex conditions, general practitioners are uniquely positioned to support timely diagnosis, referral pathways, and patient access to innovative therapies which is why we’d love to speak to you!

The discussion will also explore how primary care can contribute to successful patient identification and enrolment initiatives, helping ensure that eligible patients across Victoria have the opportunity to be considered for treatment.

This evening will provide an opportunity to engage with leading specialists, ask questions, and better understand the role of primary care in supporting access to this promising therapeutic advancement. We would be delighted to have you join us for what promises to be an informative and collaborative discussion.

Hear from our keynote speaker:

Professor Stephen Nicholls, Director Victorian Heart Institute, Victorian Heart Hospital, Monash Velos Accelerator

Program highlights:

• The clinical science behind this novel genetic medicine
• Identification of potential candidates in primary care
• Referral pathways and enrolment processes across participating Victorian hospitals
• Opportunities for collaboration between GPs, hospitals, and specialist centres to improve patient access